Literature DB >> 27908871

Regarding "Computer-Extracted Texture Features to Distinguish Cerebral Radionecrosis from Recurrent Brain Tumors on Multiparametric MRI: A Feasibility Study".

A D Schweitzer1, G C Chiang1, J Ivanidze1,2, H Baradaran1,2, R J Young2, R D Zimmerman1.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27908871      PMCID： PMC7959997          DOI： 10.3174/ajnr.A5019

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN： 0195-6108            Impact factor:   3.825


× No keyword cloud information.
  6 in total

1.  Dynamic contrast enhanced T1 MRI perfusion differentiates pseudoprogression from recurrent glioblastoma.

Authors:  Alissa A Thomas; Julio Arevalo-Perez; Thomas Kaley; John Lyo; Kyung K Peck; Weiji Shi; Zhigang Zhang; Robert J Young
Journal:  J Neurooncol       Date:  2015-08-15       Impact factor: 4.130

2.  Computer-Extracted Texture Features to Distinguish Cerebral Radionecrosis from Recurrent Brain Tumors on Multiparametric MRI: A Feasibility Study.

Authors:  P Tiwari; P Prasanna; L Wolansky; M Pinho; M Cohen; A P Nayate; A Gupta; G Singh; K J Hatanpaa; A Sloan; L Rogers; A Madabhushi
Journal:  AJNR Am J Neuroradiol       Date:  2016-09-15       Impact factor: 3.825

Review 3.  MR perfusion-weighted imaging in the evaluation of high-grade gliomas after treatment: a systematic review and meta-analysis.

Authors:  Praneil Patel; Hediyeh Baradaran; Diana Delgado; Gulce Askin; Paul Christos; Apostolos John Tsiouris; Ajay Gupta
Journal:  Neuro Oncol       Date:  2016-08-08       Impact factor: 12.300

4.  Glioblastoma treated with concurrent radiation therapy and temozolomide chemotherapy: differentiation of true progression from pseudoprogression with quantitative dynamic contrast-enhanced MR imaging.

Authors:  Tae Jin Yun; Chul-Kee Park; Tae Min Kim; Se-Hoon Lee; Ji-Hoon Kim; Chul-Ho Sohn; Sung-Hye Park; Il Han Kim; Seung Hong Choi
Journal:  Radiology       Date:  2014-10-21       Impact factor: 11.105

5.  A prospective trial of dynamic contrast-enhanced MRI perfusion and fluorine-18 FDG PET-CT in differentiating brain tumor progression from radiation injury after cranial irradiation.

Authors:  Vaios Hatzoglou; T Jonathan Yang; Antonio Omuro; Igor Gavrilovic; Gary Ulaner; Jennifer Rubel; Taylor Schneider; Kaitlin M Woo; Zhigang Zhang; Kyung K Peck; Kathryn Beal; Robert J Young
Journal:  Neuro Oncol       Date:  2015-12-19       Impact factor: 12.300

6.  The Added Prognostic Value of Metabolic Tumor Size on FDG-PET at First Suspected Recurrence of Glioblastoma Multiforme.

Authors:  Gloria C Chiang; Naveen Galla; Richard Ferraro; Ilhami Kovanlikaya
Journal:  J Neuroimaging       Date:  2016-08-12       Impact factor: 2.486
  6 in total
  1 in total

Review 1.  Radiomics in immuno-oncology.

Authors:  Z Bodalal; I Wamelink; S Trebeschi; R G H Beets-Tan
Journal:  Immunooncol Technol       Date:  2021-04-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.